Evidence map›Paper›PMID 33842613›Full record

ArticleAnnals of translational medicine2021

Supercapsular percutaneously-assisted total hip (SuperPath) versus mini-incision posterolateral total hip arthroplasty for hip osteoarthritis: a prospective randomized controlled trial.

Weikun Meng, Liang Gao, Zhong Huang, Haoyang Wang, Duan Wang, Zeyu Luo, Yang Bai, Guanglin Wang, Zongke Zhou

Abstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weikun MengDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Liang GaoCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Zhong HuangDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Haoyang WangDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Duan WangDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Zeyu LuoDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Yang BaiDepartment of Immunization, Yunnan Center for Disease Control and Prevention, Kunming, China.
Guanglin WangDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Zongke ZhouDepartment of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSupercapsular percutaneously-assisted total hip (SuperPath) arthroplasty has been proposed to be minimally invasive and tissue sparing, with possible superior postoperative outcomes compared with conventional approaches for total hip arthroplasty (THA). However, previous studies have underlined the shortcomings of conventional THA approaches, including higher dislocation, more blood loss, longer incisions, more tissue damage, and delayed postoperative rehabilitation. In the present study, we compared the short-term outcomes of unilateral THA with those of SuperPath and the mini-incision posterolateral approach (PLA) for hip osteoarthritis (OA).

methodsPatients with unilateral hip OA were prospectively recruited and underwent either SuperPath (SuperPath group) or mini-incision PLA THA (PLA group). Perioperative status [operative time, incision length, intraoperative blood loss, soft tissue damage, and length of hospital stay (LOS)], and postoperative function outcomes, including range of motion (ROM), pain visual analog scale (VAS), and Harris Hip Score (HHS), were evaluated and compared between the groups at scheduled time points within 12 months postoperatively.

resultsCompared with the PLA group, the SuperPath group yielded a significantly shorter incision length (7.83

conclusionsSuperPath may be a promising, minimally invasive technique for the treatment of OA in the future. Further investigation is necessary to evidence the possible superiority of SuperPath over other conventional mini-incision THA approaches.

Indexed as

hip osteoarthritis (hip OA)Minimally invasive surgeryposterolateral approach (PLA)supercapsular percutaneously-assisted total hip arthroplasty (SuperPath arthroplasty)total hip arthroplasty (THA)

Identifiers

PMID33842613
PMCPMC8033341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.